[The mechanisms of the development of secondary exacerbation during laser therapy in patients with ischemic heart disease and the possible ways to prevent it].
In view of possible exacerbation of ischemic heart disease in laser therapy as a result of structural modification of biomembranes it is suggested to prevent secondary exacerbation by combination of laser therapy with membranoprotectors including antioxidants, lipase inhibitors, phospholipases and essential phospholipids.